The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
Crossref DOI link: https://doi.org/10.1186/s12879-016-2106-x
Published Online: 2017-01-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Young, Jim
Weis, Nina
Hofer, Harald
Irving, William
Weiland, Ola
Giostra, Emiliano
Pascasio, Juan Manuel
Castells, Lluis
Prieto, Martin
Postema, Roelien
Lefevre, Cinira
Evans, David
Bucher, Heiner C.
Calleja, Jose Luis
Funding for this research was provided by:
Bristol-Myers Squibb
